Reports Q4 revenue $126.8M, consensus $125.04M. “In 2023, particularly the latter half, we saw challenges both for InMode and the aesthetics industry, including the surgical aesthetic sector,” said Moshe Mizrahy, Chairman and CEO. “However, we successfully introduced two exciting platforms, Define and Envision, which gained substantial market traction. “Looking ahead, we plan to launch 2 new platforms this year and believe that our market share will continue to grow as we introduce new and innovative technologies for minimally invasive aesthetics treatments. Our unique technology and continued commitment to bringing new platforms to market are pivotal in establishing InMode as a global leader in the aesthetics medical device industry worldwide,” Moshe Mizrahy concluded.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on INMD:
- InMode Reports Fourth Quarter and Full Year 2023 Financial Results; Quarterly Revenue of $126.8M and Record Full Year Revenue of $492M
- Inmode (INMD) Q4 Earnings Cheat Sheet
- InMode Stock (NASDAQ:INMD): 2 Catalysts That Can Send Shares Skyrocketing
- InMode price target lowered to $32 from $33 at Barclays
- InMode downgraded to Hold from Buy at Canaccord
